PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-08-14

Date Title Company
14-Aug-2024 GLG Life Tech Corporation Reports 2024 Second Quarter Financial Results AccessWire
14-Aug-2024 Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property AccessWire
14-Aug-2024 Medicure Reports Financial Results for Quarter Ended June 30, 2024 AccessWire
14-Aug-2024 Acreage Reports Second Quarter 2024 Financial Results AccessWire
14-Aug-2024 Interactive Strength Inc. (Nasdaq: TRNR) Reports Second Quarter 2024 Results AccessWire
14-Aug-2024 Ensysce Biosciences Reports Second Quarter 2024 Financial Results AccessWire
14-Aug-2024 Monogram Technologies Reports Second Quarter 2024 Financial Results AccessWire
14-Aug-2024 Zomedica Announces Second Quarter 2024 Financial Results: Revenue of $6.1 Million; 71% Gross Margin, and $83.0 Million in Liquidity to Support Growth AccessWire
14-Aug-2024 NHI Announces Public Offering Of Common Stock AccessWire
14-Aug-2024 Spero Clinic Offers Hope for Long COVID Patients AccessWire
14-Aug-2024 Intelliguard, Cencora Partner to Increase Compatibility of RFID-Tagged Medications, Medication Management Systems Intelliguard
14-Aug-2024 Half-year financial statements close with balanced EBITDA, Trauma with positive EBITDA aap Implantate AG
14-Aug-2024 OrganaBio Manufactures First GMP Cryopreserved Leukopaks for Two New Biopharma Partners’ Allogeneic Cell Therapies OrganaBio
14-Aug-2024 Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Blue Earth Therapeutics Ltd
14-Aug-2024 SpyBiotech Appoints Dr. Prakash Bhuyan as Chief Medical Officer SpyBiotech
14-Aug-2024 Breakthrough heart MRI technique accurately predicts heart failure risk in general population The University of East Anglia (UEA)
14-Aug-2024 Cellomatics underpins continued US and European expansion with two business development hires Cellomatics Biosciences
14-Aug-2024 Santhera Closes Financings and Secures Funds to Reach Break-Even Expected in 2026 Santhera Pharmaceuticals
14-Aug-2024 New scientific article on NeuroRestore ACD856 and its improved cognition and disease modification of Alzheimer’s disease New scientific article on NeuroRestore ACD856 and its improved cognition and disease modification of Alzheimer’s disease
14-Aug-2024 PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors PureTech Health plc